港股异动 | 剂泰科技-P(07666)涨近5% 与Deerfield达成战略联盟共同开发AI驱动蛋白药物与体内免疫疗法

智通财经06-01

智通财经APP获悉，剂泰科技-P(07666)涨近5%，截至发稿，涨4.47%，报15.44港元，成交额822.35万港元。消息面上，5月28日，据剂泰科技官微消息，公司宣布与全球顶级健康投资与创新平台Deerfield Management(以下简称“Deerfield”)达成战略联盟。双方将共同开发新一代体内蛋白药物(in vivo protein therapeutics)及免疫疗法，并共同...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2640982211?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-01 10:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640982211","market":"us","top_or_hot":-1,"title":"港股异动 | 剂泰科技-P(07666)涨近5% 与Deerfield达成战略联盟 共同开发AI驱动蛋白药物与体内免疫疗法","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，剂泰科技-P(07666)涨近5%，截至发稿，涨4.47%，报15.44港元，成交额822.35万港元。消息面上，5月28日，据剂泰科技官微消息，公司宣布与全球顶级健康投资与创新平台Deerfield Management(以下简称“Deerfield”)达成战略联盟。双方将共同开发新一代体内蛋白药物(in vivo protein therapeutics)及免疫疗法，并共同...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1448308.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 剂泰科技-P(07666)涨近5% 与Deerfield达成战略联盟 共同开发AI驱动蛋白药物与体内免疫疗法</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 剂泰科技-P(07666)涨近5% 与Deerfield达成战略联盟 共同开发AI驱动蛋白药物与体内免疫疗法\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-01 10:15 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1448308.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，剂泰科技-P(07666)涨近5%，截至发稿，涨4.47%，报15.44港元，成交额822.35万港元。消息面上，5月28日，据剂泰科技官微消息，公司宣布与全球顶级健康投资与创新平台Deerfield Management(以下简称“Deerfield”)达成战略联盟。双方将共同开发新一代体内蛋白药物(in vivo protein therapeutics)及免疫疗法，并共同...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1448308.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CHAT","symbol_name":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1448308.html","article_id":"2640982211","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2640982211","pubTimestamp":1780280137,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，剂泰科技-P涨近5%，截至发稿，涨4.47%，报15.44港元，成交额822.35万港元。消息面上，5月28日，据剂泰科技官微消息，公司宣布与全球顶级健康投资与创新平台Deerfield Management达成战略联盟。Deerfield将就剂泰科技自研AI纳米递送平台NanoForge及其驱动解决方案和核心管线项目在全球临床开发和商务拓展举措方面开展深度合作。其中包括剂泰科技自研AiProtein平台发现并推进至临床前候选药物阶段的一项领先T细胞衔接器项目。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","AGIX":"通用人工智能 ETF-AGIX","ARTY":"ISHARES FUTURE AI & TECH ETF","BK1161":"生物科技","AIPO":"Defiance AI and Power Infrastructure ETF","BK4585":"ETF&股票定投概念","BK4588":"碎股","07666":"剂泰科技-P","VXUS":"国际股票ETF-Vanguard"},"translate_title":"Hong Kong stock changes | Jitai Technology-P (07666) rose nearly 5% and reached a strategic alliance with Deerfield to jointly develop AI driver protein drugs and in vivo immunotherapy","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AGIX":1.5,"AIPO":1.5,"ARTY":1.5,"VXUS":1.5,"07666":1.5,"CHAT":1.5},"content_text":"智通财经APP获悉，剂泰科技-P(07666)涨近5%，截至发稿，涨4.47%，报15.44港元，成交额822.35万港元。消息面上，5月28日，据剂泰科技官微消息，公司宣布与全球顶级健康投资与创新平台Deerfield Management(以下简称“Deerfield”)达成战略联盟。双方将共同开发新一代体内蛋白药物(in vivo protein therapeutics)及免疫疗法，并共同推进合作管线产品的全球商业化进程。Deerfield将就剂泰科技自研AI纳米递送平台NanoForge及其驱动解决方案和核心管线项目在全球临床开发和商务拓展举措方面开展深度合作。其中包括剂泰科技自研AiProtein平台发现并推进至临床前候选药物(PCC)阶段的一项领先T细胞衔接器(T-cell engager, TCE)项目。Deerfield将进一步探索该项目潜在授权与开发机会，以推动其进入IND支持性研究和临床开发阶段。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2640982211","isCrawlerRequest":true}

港股异动 | 剂泰科技-P(07666)涨近5% 与Deerfield达成战略联盟 共同开发AI驱动蛋白药物与体内免疫疗法

精彩评论

港股异动 | 剂泰科技-P(07666)涨近5% 与Deerfield达成战略联盟共同开发AI驱动蛋白药物与体内免疫疗法